Pearl Health vs Reveleer (2026)
Two products a risk bearing primary care organisation uses at different points in the year. Pearl predicts which attributed Medicare patients are heading for avoidable cost so care teams can reach them before it happens, across thousands of providers. Reveleer works the other end, retrieving records, parsing charts and populating risk adjustment and quality submissions once the visits are done. They are sequential rather than competing, and most organisations under risk need both. The shared unanswered question is directional: Pearl decides who gets contacted and publishes no subgroup performance, so the patients it deprioritises are invisible in every metric it reports, and Reveleer should be asked how many codes its review removes against how many it adds.
- It predicts which Medicare patients are heading for avoidable cost so care teams can reach them first, across thousands of providers and hundreds of thousands of attributed beneficiaries.
- Prioritisation is the product rather than a feature, which is the operational question a small primary care practice under risk actually has.
- Scope is stated precisely by population and programme rather than as value based care in general.
- It works retrospectively across retrieval, chart parsing and both risk adjustment and quality submissions, which is how a contract year is closed.
- Retrieval is the hard part of retrospective work and it owns that step rather than assuming charts arrive.
- One workflow serving two regulatory obligations suits an organisation carrying both.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Pearl Health and Reveleer are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Pearl Health | Reveleer |
|---|---|---|
| Primary category | Value Based Care Intelligence | Value Based Care Intelligence |
| Founded | Not recorded | 2009 |
| Headquarters | New York, New York | Glendale, California, United States |
| Website | pearlhealth.com | reveleer.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Pearl Health its top capability grade on Setting and Specialty Coverage. Set against Reveleer, Pearl Health grades higher on Model Supply Chain Disclosure, HIPAA and BAA Posture and Setting and Specialty Coverage. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index records no top capability grade for Reveleer on any axis it scores. Set against Pearl Health, Reveleer grades higher on Autonomy and Oversight Model. Its thinnest published disclosure sits on Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Pearl Health or Reveleer?
On the axes where the AI Health Index separates them, Pearl Health grades higher on Model Supply Chain Disclosure, HIPAA and BAA Posture and Setting and Specialty Coverage, and Reveleer grades higher on Autonomy and Oversight Model. Pearl Health leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Pearl Health and Reveleer differ most?
The widest separation the AI Health Index records between Pearl Health and Reveleer is on Model Supply Chain Disclosure, where Pearl Health grades C and Reveleer grades D. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Pearl Health and Reveleer grade the same?
The AI Health Index grades Pearl Health and Reveleer the same on several axes, including AI Centrality, Model and Technology Transparency and Clinical and Operational Evidence. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Pearl Health and Reveleer not disclosed?
At the last review, at least one of Pearl Health and Reveleer published thin or absent detail on Model Supply Chain Disclosure. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Value Based Care Intelligence page.
These are sequential inside the same contract year rather than alternatives, one deciding who to reach and the other reconstructing what happened. Both sit on the documentation incentive and neither publishes a two way number: prioritisation models decide who gets contacted and publish no subgroup performance, so patients systematically deprioritised are invisible in every metric, and retrospective platforms should be asked their ratio of codes removed to codes added. Neither publishes pricing.